Skip to main content
Log in

Assessment of dermal uptake of diphenylmethane-4,4’-diisocyanate using tape stripping and biological monitoring

  • Investigative Report
  • Published:
European Journal of Dermatology Aims and scope

Abstract

Background

Very little is known about the dermal uptake of isocyanates, and dermal exposure to isocyanates has been discussed as a factor involved in the induction of respiratory diseases.

Objectives

To investigate the dermal uptake of diphenylmethane-4,4’-diisocyanate (4,4’-MDI).

Materials & Methods

Four volunteers were dermally exposed to 10, 25, 49 and 50 mg 4,4’-MDI, respectively, for eight hours. The exposed areas were tape stripped. Urine and blood were biologically monitored for 48 hours. Tape strips, plasma, and urine were analysed by liquid chromatography-mass spectrometry.

Results

In total, 35-70% of the applied dose of 4,4’-MDI was absorbed by the skin. Very low fractions of applied dose were found in the tape strips. The 4,4’-MDA concentration in plasma and urine was low, but peaked in urine at 10-14 hours and plasma at 8-32 hours after exposure.

Conclusions

4,4’-MDI is readily absorbed by human skin. Only small fractions of 4,4’-MDI remain as such in the superficial skin layers. The amounts found in blood and urine were only small fractions of the total applied doses which indicates that very small amounts of 4,4’-MDI penetrate the skin and reach the blood stream. The dermal uptake and distribution of 4,4’-MDI is much slower compared to that associated with airway uptake. Our data strongly indicate that formation of 4,4’-MDA from 4,4’-MDI upon reacting with water in the skin can only occur to a very limited extent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McDonald JC, Chen Y, Zekveld C, Cherry NM. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med 2005; 62: 836–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Redlich CA. Skin exposure and asthma: is there a connection? Proc Am Thorac Soc 2010; 7: 134–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Redlich CA, Herrick CA. Lung/skin connections in occupational lung disease. Curr Opin Allergy Clin Immunol 2008; 8: 115–9.

    Article  PubMed  CAS  Google Scholar 

  4. Rattray NJ, Botham PA, Hext PM, et al. Induction of respiratory hypersensitivity to diphenylmethane-4,4’-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology 1994; 88: 15–30.

    PubMed  CAS  Google Scholar 

  5. Engfeldt M, Isaksson M, Zimerson E, Bruze M. Several cases of work-related allergic contact dermatitis caused by isocyanates at a company manufacturing heat exchangers. Contact Dermatitis 2013; 68: 175–80.

    Article  PubMed  Google Scholar 

  6. Agency SC. The Swedish Chemicals Agency’s Classification and labelling regulations (KIFS 7). Stockholm, 2005.

    Google Scholar 

  7. Engfeldt M, Goossens A, Isaksson M, Zimerson E, Bruze M. The outcome of 9 years of consecutive patch testing with 4,4’-diaminodiphenylmethane and 4,4’-diphenylmethane diisocyanate. Contact Dermatitis 2013; 68: 98–102.

    Article  PubMed  CAS  Google Scholar 

  8. Hoffmann HD, Leibold E, Ehnes C, et al. Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI. Toxicol Let 2010; 199: 364–71.

    CAS  Google Scholar 

  9. Vock EH, Lutz WK. Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4’-diisocyanate (MDI) in the rat after topical treatment. Toxicol Let 1997; 92: 93–100.

    Article  CAS  Google Scholar 

  10. Bello D, Smith TJ, Woskie SR, et al. An FTIR investigation of isocyanate skin absorption using in vitro guinea pig skin. J Environ Monit 2006; 8: 523–9.

    Article  PubMed  CAS  Google Scholar 

  11. Hamada H, Isaksson M, Bruze M, et al. Dermal uptake study with 4,4’-diphenylmethane diisocyanate led to active sensitization. Contact Dermatitis 2012; 66: 101–5.

    Article  PubMed  CAS  Google Scholar 

  12. Fent KW, Jayaraj K, Gold A, Ball LM, Nylander-French LA. Tapestrip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. Scand J Work Environ Health 2006; 32: 225–40.

    Article  PubMed  CAS  Google Scholar 

  13. Sennbro CJ, Lindh CH, Tinnerberg H, et al. Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4-and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4’-methylenediphenyl diisocyanate. Biomarkers 2003; 8: 204–17.

    Article  PubMed  CAS  Google Scholar 

  14. Robert A, Ducos P, Francin JM, Marsan P. Biological monitoring of workers exposed to 4,4’-methylenediphenyl diisocyanate (MDI) in 19 French polyurethane industries. Int Arch Occup Environ Health 2007; 80: 412–22.

    Article  PubMed  CAS  Google Scholar 

  15. Vock EH, Hoymann HG, Heinrich U, Lutz WK. 32P-postlabeling of a DNA adduct derived from 4,4’-methylenedianiline, in the olfactory epithelium of rats exposed by inhalation to 4,4’-methylenediphenyl diisocyanate. Carcinogenesis 1996; 17: 1069–73.

    Article  PubMed  CAS  Google Scholar 

  16. Sepai O, Henschler D, Sabbioni G. Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4’-methylenediphenyl diisocyanate. Carcinogenesis 1995; 16: 2583–7.

    Article  PubMed  CAS  Google Scholar 

  17. Schutze D, Sepai O, Lewalter J, Miksche L, Henschler D, Sabbioni G. Biomonitoring of workers exposed to 4,4’-methylenedianiline or 4,4’-methylenediphenyl diisocyanate. Carcinogenesis 1995; 16: 573–82.

    Article  PubMed  CAS  Google Scholar 

  18. Kim HO, Wester RC, McMaster JA, Bucks DA, Maibach HI. Skin absorption from patch test systems. Contact Dermatitis 1987; 17: 178–80.

    Article  PubMed  CAS  Google Scholar 

  19. Pauluhn J, Lewalter J. Analysis of markers of exposure to polymeric methylene-diphenyl diisocyanate (pMDI) in rats: a comparison of dermal and inhalation routes of exposure. Exp Toxicol Pathol 2002; 54: 135–46.

    Article  PubMed  CAS  Google Scholar 

  20. Sennbro CJ, Lindh CH, Mattsson C, Jonsson BA, Tinnerberg H. Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4’-methylenediphenyl diisocyanate. Int Arch Occup Environ Health 2006; 79: 647–53.

    Article  PubMed  CAS  Google Scholar 

  21. Kaaria K, Hirvonen A, Norppa H, Piirila P, Vainio H, Rosenberg C. Exposure to 4,4’-methylenediphenyl diisocyanate (MDI) during moulding of rigid polyurethane foam: determination of airborne MDI and urinary 4,4’-methylenedianiline (MDA). Analyst 2001; 126: 476–9.

    Article  PubMed  CAS  Google Scholar 

  22. Pearson RL, Logan PW, Kore AM, Strom CM, Brosseau LM, Kingston RL. Isocyanate exposure assessment combining industrial hygiene methods with biomonitoring for end users of orthopedic casting products. Ann Occup Hyg 2013; 57: 758–65.

    PubMed  PubMed Central  CAS  Google Scholar 

  23. Hotchkiss SA, Hewitt P, Caldwell J. Percutaneous absorption of 4,4’-methylene-bis (2-chloroaniline) and 4,4’-methylenedianiline through rat and human skin in vitro. Toxicol In Vitro 1993; 7: 141–8.

    Article  PubMed  CAS  Google Scholar 

  24. Brunmark P, Bruze M, Skerfving S, Skarping G. Biomonitoring of 4,4’ methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans. Int Arch Occup Environ Health 1995; 67: 95–100.

    Article  PubMed  CAS  Google Scholar 

  25. Frick-Engfeldt M, Isaksson M, Zimerson E, Bruze M. How to optimize patch testing with diphenylmethane diisocyanate. Contact Dermatitis 2007; 57: 138–51.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haneen Hamada.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamada, H., Liljelind, I., Bruze, M. et al. Assessment of dermal uptake of diphenylmethane-4,4’-diisocyanate using tape stripping and biological monitoring. Eur J Dermatol 28, 143–148 (2018). https://doi.org/10.1684/ejd.2018.3247

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3247

Key words

Navigation